Bengaluru-based quick medicine delivery startup Plazza has raised $15 million in a Series A funding round co-led by Accel, Elevation Capital and Nexus Venture Partners. Existing investors All In Capital and Better Capital also participated in the round, which comes about 10 months after Plazza’s $1.4 million seed raise.
The company plans to use the fresh capital to expand its store network, strengthen its technology platform, and deepen its AI-driven inventory and assortment intelligence. Founder and CEO Aman Priyadarshi said Plazza will quickly launch around 10 new stores in Bengaluru in the next eight weeks and aims to operate about 20 stores in the city by end-2026.
Plazza focuses on 15–30 minute delivery of prescription and over‑the‑counter medicines through a hyperlocal pharmacy network. The startup sees quick commerce’s next big race moving into medicine delivery, where speed, reliability and supply are critical for users. With this funding, Plazza wants to scale its model beyond Bengaluru and build a dense network of small, tech-enabled pharmacy outlets.
For investors, the bet is on Plazza’s mix of physical stores, AI-based demand forecasting and tight control over inventory and compliance. The round is expected to value the company at around $50 million, as it looks to double down on hyperlocal fulfilment and expand to more Indian cities in the next few years.
FAQs [Frequently Asked Questions]
Q1: What will Plazza use the $15 million funding for?
A: Plazza will use the $15 million to open more pharmacy stores, expand to new cities, and strengthen its AI-powered inventory, assortment and delivery technology for faster, reliable medicine fulfilment.
Q2: Who led Plazza’s Series A funding round?
A: The Series A round was co-led by Accel, Elevation Capital and Nexus Venture Partners, with participation from existing investors All In Capital and Better Capital, about 10 months after its seed round.
Q3: How fast does Plazza deliver medicines and where is it operating?
A: Plazza targets 15–30 minute delivery of prescription and OTC medicines via a hyperlocal store network, currently piloting in Bengaluru and planning around 20 stores in the city by end-2026.